PRGO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Perrigo Company PLC (PRGO) is not a strong buy at the moment for a long-term beginner investor. While there are some positive catalysts such as insider buying and share gains in certain business segments, the company's financial performance and overall sentiment do not support a strong buy recommendation. The stock may be more suitable for monitoring rather than immediate investment.
The MACD is positive at 0.253, indicating a mild bullish trend, but it is contracting. RSI is at 72.301, which is neutral. Moving averages are converging, showing no clear directional trend. The stock is trading near its resistance level (R1: 11.477), suggesting limited upside potential in the short term.
Insider buying has increased by 107.21% over the last month. The company has reported share gains in private label store brands and key branded businesses despite challenges in the infant nutrition segment.
Gross margin dropped by -3.72% YoY, and the company posted a significant net income loss of -$1.42 billion. Analysts have lowered price targets recently, citing challenges in the infant nutrition business.
In Q4 2025, revenue dropped to $1.11 billion (-2.52% YoY). Net income increased to -$1.42 billion, up 3086.74% YoY, primarily due to prior losses. EPS increased to -$10.31, up 3121.88% YoY, but remains negative. Gross margin dropped to 32.64%, down -3.72% YoY.
JPMorgan lowered its price target to $15 from $18 and maintains a Neutral rating. Canaccord lowered its price target to $17 from $20 but maintains a Buy rating, citing challenges in the infant nutrition segment but strength in other areas of the business.
